Left Panel- Inhibition of CYP2C9.1 (wild-type) mediated flubriprofen 41-hydroxylation
by increasing concentrations of benzbromarone.
Right Panel- Activation of CYP2C9.3 (I359L) mediated flurbiprofen 4-hydroxylation by
increasing concentrations of benzbromarone.